TNF and rheumatoid arthritis: These agents have demonstrated efficacy in reducing inflammation and joint damage in rheumatoid arthritis by neutralizing TNF-α and alleviating the inflammatory symptoms of psoriasis by targeting IL-17 and IL-23 (105).